Kairos Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 7
Employees
  • Latest Deal Type
  • M&A

Kairos Therapeutics General Information

Description

Developer of antibody-drug conjugate therapeutics for cancer. The company provides an antibody-drug conjugate platform that enables development of therapeutics for the treatment of multiple forms of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Acquirer
Primary Office
  • 2405 Wesbrook Mall
  • Fourth Floor
  • Vancouver, British Columbia V6T 1Z3
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kairos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 22-Mar-2016 Completed Startup
1. Early Stage VC 12-Dec-2013 Completed Startup
To view Kairos Therapeutics’s complete valuation and funding history, request access »

Kairos Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of antibody-drug conjugate therapeutics for cancer. The company provides an antibody-drug conjugate platform t
Biotechnology
Vancouver, Canada
7 As of 2016
000000&0

000 0000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
000000000 00000 (0000000000)
Chester, United Kingdom
00 As of 0000
000.00
000000000000 000.00

00000000

is nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000 000000000
San Carlos, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kairos Therapeutics Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ADC Biotechnology Venture Capital-Backed Chester, United Kingdom 00 000.00 000000000000 000.00
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
0000000 Formerly Accelerator/Incubator backed San Francisco, CA 0 000000&0
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
000000 00000000000 Private Equity-Backed Abingdon, United Kingdom 00 000.00 0000000 0000 000.00
You’re viewing 5 of 22 competitors. Get the full list »

Kairos Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
John Babcook Co-Founder, Chief Scientific Officer & President
To view Kairos Therapeutics’s complete executive team members history, request access »

Kairos Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kairos Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CDRD Ventures Corporate Venture Capital Minority 000 0000 000000 0
To view Kairos Therapeutics’s complete investors history, request access »